FiercePharma13d
Xeris, stymied by forgetful physicians, partners with ADA to raise awareness of need for glucagon
Xeris Pharmaceuticals has teamed up with the American Diabetes Association (ADA) to raise awareness of the importance of ...
Websites selling compounded GLP-1 RAs often misinform consumers, research reveals
Websites that sell compounded glucagon-like peptide-1 receptor agonists (GLP-1 RAs) often partially inform or misinform ...
Medscape17y
Nocturnal Hypoglycemia: Answering the Challenge With Long-acting Insulin Analogs
Subcutaneous glucagon administration is recommended if the hypoglycemic episode is suspected to be severe (ie, if the patient is asleep and cannot be aroused). [40] Convenient glucagon kits with ...
Medscape21d
Glucagon Prescriptions Still Fall Short of Meeting Demand
Glucagon prescriptions for severe hypoglycemia in Medicaid initially decreased from 2012 to 2018 but increased between 2019 and 2023 following the introduction of newer products. Glucagon ...
ohiocapitaljournal8d
Two Ohio doctors and their clinics disciplined over weight loss drugs
Clinics in Columbus, Cleveland, Dayton, and Cincinnati have lost their licenses to distribute dangerous drugs after the Ohio ...
Study ties Ozempic-like drugs to dozens of benefits and risks
Weight loss drugs like Ozempic and Wegovy have been tied in a large, national study to a drop in the risk of developing dozens of health conditions. But the semaglutide-like drugs also appear to ...
HealthDay on MSN14d
Websites Selling Compounded GLP-1 RAs Often Misinform Consumers
Websites that sell compounded glucagon-like peptide-1 receptor agonists (GLP-1 RAs) often partially inform or misinform ...